Teva Pharmaceutical Industries has announced the launch of a generic equivalent of Ortho Tri-Cyclen® Lo (norgestimate/ethinyl estradiol) tablets in the United States. Teva’s Tri-Lo-Sprintec®(norgestimate and ethinyl estradiol tablets, USP) is an oral contraceptive, available in a 28-day blister pack dispenser, used by women to prevent pregnancy.
Ortho Tri-Cyclen® Lo (norgestimate/ethinyl estradiol) tablets, marketed by Janssen Pharmaceuticals, Inc., had annual sales of approximately $488 million in the United States, according to IMS data as of October 2015.